共查询到19条相似文献,搜索用时 62 毫秒
1.
生物共振治疗变应性疾病临床疗效分析 总被引:3,自引:1,他引:3
利用生物共振治疗系统将过敏原生物波逆转、放大后输回体内进行脱敏治疗。结果:脱敏治疗的157例患者有效率73.9%、痊愈率44.6%。生物共振治疗系统治疗变应性疾病疗效显著、无痛苦、无不良反应,对小儿患者尤为适宜。 相似文献
2.
生物共振系统治疗小儿过敏性疾病临床疗效观察 总被引:2,自引:0,他引:2
使用德国BICOM2000生物共振仪,对68例小儿过敏性疾病患者进行变应原检测及脱敏治疗,评价其临床疗效,所用过敏原标本共490种。确定信息点,选择测试程序,逐一测定过敏原标本;将变应原生物波逆转,放大后输回人体进行脱敏治疗结果:生物共振系统脱敏治疗的痊愈率为55.9%,总行效率为79.4%。在治疗过敏性疾病方面,生物共振治疗系统具有较高的疗效,且无副作用。 相似文献
3.
目的 使用百康生物共振治疗系统对80例慢性湿疹患者针对变应原进行脱敏治疗。方法 将变应原生物波逆转、放大后输回人体,对80例慢性湿疹患者进行脱敏治疗。结果 生物共振治疗系统脱敏治疗的80例患者有效率为85.0%,痊愈率为32.5%。结论 生物共振治疗系统治疗慢性湿疹疗效较佳,无任何不良反应。 相似文献
4.
百康生物共振治疗系统治疗荨麻疹54例临床疗效观察 总被引:2,自引:1,他引:1
我科于2004年1~6月采用德国生产的百康生物共振系统(Bicom-bioresonace therapy)对54例荨麻疹患者进行变应原检测和脱敏治疗,结果报道如下。 相似文献
5.
生物共振系统治疗小儿过敏性疾病临床疗效观察 总被引:2,自引:0,他引:2
临床上以往检测过敏原方法很多,但都有痛苦,尤其不适合儿童病人,而且以往过敏原检测手段只能检测不能快速脱敏.笔者应用百康生物共振治疗系统(德国REGUMED公司生产)对68例小儿过敏性疾病患者进行了变应原检测及脱敏治疗,取得较好的疗效,现将结果报告如下. 相似文献
6.
7.
百康生物共振治疗系统治疗湿疹皮炎45例疗效观察 总被引:2,自引:0,他引:2
目的 评价百康生物共振治疗系统在湿疹皮炎患者过敏原检测及脱敏治疗方面的作用。方法 使用生物共振技术,将致敏信号检测出,逆转过敏原产生的共振信息波,将该逆转共振波进行高倍放大后回输入人体,对湿疹皮炎类患者进行脱敏治疗。结果 应用百康生物共振治疗系统治疗的45例湿疹皮炎的基愈率为40.0%,有效率为82.22%。结论 百康生物共振治疗系统可有效地治疗湿疹皮炎类皮肤病,无任何不良反应。 相似文献
8.
我们采用德国Regumed公司生产的百康生物共振治疗系统,于2005年1~10月对164例慢性荨麻疹患者进行脱敏治疗,现将结果报道如下。 相似文献
9.
2005年3~7月我院皮肤科采用德国百康(BICOM)生物共振治疗仪治疗过敏性皮肤病196例,对其中较具代表性的89例皮肤病患者进行临床疗效统计,并追踪观察疗效,脱敏治疗总有效率76.4%。报道如下。临床资料89例患者中,湿疹49例,荨麻疹28例,脂溢性皮炎9例,神经性皮炎3例,病程1周至十余年 相似文献
10.
德国产百康生物共振治疗仪(BI COM2000型)是目前唯一集过敏原检测、脱敏治疗于一体的先进仪器。具有无创伤、无痛苦、不用药物治疗、脱敏疗效显著的优点。笔者于2004年3月~7月对186例过敏性皮肤病患者进行过敏原检测和临床治疗观察,总结报道如下。临床资料186例患者均为我院门 相似文献
11.
This review defines the term "compound allergy" in the context of new findings, and discusses evidence that allergenic reaction products have been identified. Material was gathered by searching Index Medicus and the Science Citation Index, and reviewing several standard texts. Issues regarding the validity of patch lest results are addressed and we introduce the term "pseudcompound allergy" to cover cases of false-negative patch tests. We present new theories regarding the mechanisms by which new allergens arc formed and a means of classification. 相似文献
12.
Food and inhalant allergens have also been identified as potential trigger factors of atopic dermatitis symptoms. Here we aimed to investigate relationships between atopic dermatitis and inhalant‐food allergen sensitization in Turkish children with atopic dermatitis. We included 70 patients (42 male, 28 female) with atopic dermatitis and 45 controls (30 male, 15 female) with no atopy, no atopy familial history, no atopy clinical findings no atopic dermatitis. We noted patients' and controls' age, gender, passive smoking exposure, atopy, xerosis, bath water temperature, shower gel type, clothes detergent type, blood hemoglobin, blood eosinophil count, blood eosinophil percent, values of serum immunoglobulin E, serum immunoglobulin A, serum immunoglobulin G, serum immunoglobulin M, results of inhalant allergen, and food allergen testing. We found that nine cases had inhalant allergen sensitization and 21 cases had food allergen sensitization. There were significant relationships between cases and controls in terms of count of eosinophil and percent of eosinophil (P = .008, P = .009, respectively). Humoral and cellular allergen‐specific immune responses to food and inhalant allergens can be detected in patients with atopic dermatitis. Accordingly, we believe that blood eosinophil count and percent are more valuable laboratory parameters than serum total IgE for following patients with atopic dermatitis. 相似文献
13.
A 63-year-old woman presented with a 6-year history of persistent cheilitis. Minimal improvement was achieved with therapeutic measures. Patch testing was positive to anethole, a flavouring used in her toothpaste. Her cheilitis resolved after cessation of the flavoured toothpaste. This case demonstrates the importance of considering contact allergy to toothpaste flavours in patients with cheilitis. 相似文献
14.
15.
Bangsgaard N Thyssen JP Menné T Andersen KE Mortz CG Paulsen E Sommerlund M Veien NK Laurberg G Kaaber K Thormann J Andersen BL Danielsen A Avnstorp C Kristensen B Kristensen O Vissing S Nielsen NH Johansen JD 《Contact dermatitis》2012,67(2):73-77
Background. Epoxy resin monomers are strong skin sensitizers that are widely used in industrial sectors. In Denmark, the law stipulates that workers must undergo a course on safe handling of epoxy resins prior to occupational exposure, but the effectiveness of this initiative is largely unknown. Objectives. To evaluate the prevalence of contact allergy to epoxy resin monomer (diglycidyl ether of bisphenol A; MW 340) among patients with suspected contact dermatitis and relate this to occupation and work‐related consequences. Patients/methods. The dataset comprised 20 808 consecutive dermatitis patients patch tested during 2005–2009. All patients with an epoxy resin‐positive patch test were sent a questionnaire. Results. A positive patch test reaction to epoxy resin was found in 275 patients (1.3%), with a higher proportion in men (1.9%) than in women (1.0%). The prevalence of sensitization to epoxy resin remained stable over the study period. Of the patients with an epoxy resin‐positive patch test, 71% returned a questionnaire; 95 patients had worked with epoxy resin in the occupational setting, and, of these, one‐third did not use protective gloves and only 50.5% (48) had participated in an educational programme. Conclusion. The 1% prevalence of epoxy resin contact allergy is equivalent to reports from other countries. The high occurrence of epoxy resin exposure at work, and the limited use of protective measures, indicate that reinforcement of the law is required. 相似文献
16.
食物过敏是儿童常见的过敏性疾病,发病率逐年增高,故其诊断尤为重要,目前诊断方法包括皮肤点刺试验, 特异性IgE检测,组分过敏原测试及过敏原激发试验,本文对上述试验方法进行综述。 相似文献
17.
Malin G. Ahlstrm Jacob P. Thyssen Michael Wennervaldt Torkil Menn Jeanne D. Johansen 《Contact dermatitis》2019,81(4):227-241
Nickel is the most frequent cause of contact allergy worldwide and has been studied extensively. This clinical review provides an updated overview of the epidemiology, exposure sources, methods for exposure quantification, skin deposition and penetration, immunology, diagnosis, thresholds for sensitization and elicitation, clinical pictures, prevention, and treatment. The implementation of a nickel regulation in Europe led to a decrease in the prevalence of nickel allergy, and changes in the clinical picture and disease severity. Nevertheless, the prevalences of nickel allergy in the European general population are approximately 8% to 19% in adults and 8% to 10% in children and adolescents, with a strong female predominance. Well‐known consumer items such as jewellery and metal in clothing are still the main causes of nickel allergy and dermatitis, although a wide range of items for both private and occupational use may cause dermatitis. Allergic nickel dermatitis may be localized to the nickel exposure site, be more widespread, or present as hand eczema. Today, efficient methods for exposure quantification exist, and new insights regarding associated risk factors and immunological mechanisms underlying the disease have been obtained. Nevertheless, questions remain in relation to the pathogenesis, the persistent high prevalence, and the treatment of severe cases. 相似文献
18.